Annovis Bio, Inc.

NYSE:ANVS

4.37 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 12.6373.9983.1375.7556.35515.72516.75928.37831.98735.97442.66945.68647.45549.2245.6038.0758.8419.76311.120.0020.0560.1050.3370.035-0.347
Short Term Investments 0000000000000000000000000.695
Cash and Short Term Investments 12.6373.9983.1375.7556.35515.72516.75928.37831.98735.97442.66945.68647.45549.2245.6038.0758.8419.76311.120.0020.0560.1050.3370.0350.347
Net Receivables 00000000000000000.4250.1990.0380.73500000
Inventory 0000000000000000000.278000000
Other Current Assets 1.7250.3130.3150.0420.1287.0920.2070.1050.1980.2840.360.0730.1850.2620.3560.0380.130.2320.2830.0040.0360.0380.060.0120
Total Current Assets 14.3625.0467.81310.20810.22322.81625.54736.02232.48736.52543.29746.00147.6549.4965.9658.1199.40210.20111.4410.7480.0990.1490.40.0510.347
Non-Current Assets:
Property, Plant & Equipment, Net 0000000000000000000000000
Goodwill 0000000000000000000000000
Intangible Assets 0000000000000000000000000
Goodwill and Intangible Assets 0000000000000000000000000
Long Term Investments 0000000000000000000000000
Tax Assets 0000000000000000000000000
Other Non-Current Assets 00000000000000000000.370.2810.1510.0310-0.347
Total Non-Current Assets 00000000000000000000.370.2810.1510.0310-0.347
Total Assets 14.3625.0467.81310.20810.22322.81625.54736.02232.48736.52543.29746.00147.6549.4965.9658.1199.40210.20111.4411.1170.380.30.4310.0510
Liabilities & Equity:
Current Liabilities:
Account Payables 4.0993.3954.1071.2931.9261.1734.1533.9611.8460.9020.9290.6880.290.1150.8250.3420.140.1240.0551.2340.42500.010.0680
Short Term Debt 0000000000000000000000000
Tax Payables 0000000000000000000000000
Deferred Revenue 0000000000000000000000000
Other Current Liabilities 1.2920.6630.7632.9861.6380.9011.2583.7370.6810.3980.3270.8180.8310.7690.7720.2370.1410.5780.6950.7770.7010.7940.5980.50
Total Current Liabilities 5.3914.0574.874.2793.5652.0745.4117.6992.5271.2991.2561.5071.1210.8841.5970.5780.2810.7030.7492.0111.1260.7940.6080.5680
Non-Current Liabilities:
Long Term Debt 00000000000000000000.50.4980.4970.49600
Deferred Revenue Non-Current 0000000000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000000000
Other Non-Current Liabilities 1.9072.746.29713.680000000000000007.1837.137.137.1037.0770
Total Non-Current Liabilities 1.9072.746.29713.68004,152.943.9611.8460.9020.9290.68800000007.6837.6287.6277.5997.0770
Total Liabilities 7.2986.79711.16717.9593.5652.0745.4117.6992.5271.2991.2561.5071.1210.8841.5970.5780.2810.7030.7499.6948.7558.4218.2077.6450
Equity:
Preferred Stock 00000000000000000007.0777.0777.0777.0777.0776.833
Common Stock 0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001000000
Retained Earnings -128.985-116.346-111.326-110.259-88.046-73.329-63.792-54.055-50.96-43.339-34.62-28.726-22.812-19.963-17.439-14.239-12.534-11.528-9.219-8.777-8.576-8.322-7.977-7.7860
Accumulated Other Comprehensive Income/Loss 000000000000000-00-0-0-7.077-7.077-0-0-7.077-6.966
Other Total Stockholders Equity 136.047114.594107.971102.50794.70394.07183.92782.37780.9278.56476.6673.2269.34168.57521.80621.77921.65521.02619.910.20114.154-7.077-6.87614.1540
Total Shareholders Equity 7.064-1.751-3.354-7.7516.65820.74320.13628.32429.96135.22642.0444.49546.5348.6124.3687.5419.1219.49810.692-8.576-8.375-8.121-7.776-7.594-0.132
Total Equity 7.064-1.751-3.354-7.7516.65820.74320.13628.32429.96135.22642.0444.49546.5348.6124.3687.5419.1219.49810.692-8.576-8.375-8.121-7.776-7.594-0.132
Total Liabilities & Shareholders Equity 14.3625.0467.81310.20810.22322.81625.54736.02232.48736.52543.29746.00147.6549.4965.9658.1199.40210.20111.4411.1170.380.30.4310.051-0.132